期刊文献+

吴茱萸碱水包油型复合纳米乳的体外释放和在体吸收研究 被引量:5

Release profile and intestinal absorption of evodiamine complex oil-in-water nanoemulation
原文传递
导出
摘要 目的:研究吴茱萸碱磷脂复合物水包油型纳米乳(evodiamine nanocomplex oil-in-water nanoemulation,OECNE)体外释放特性和在胃肠吸收情况。方法:采用透析法建立OECNE体外模型,用模型拟合法和相似因子法(f2)考察其体外释放行为;应用大鼠单向肠灌流模型研究其吸收情况。结果:在pH 1.2盐酸溶液和pH 6.8磷酸缓冲溶液中,OECNE的累积释放率均约为EDA的3倍,释放曲线均符合Weibull方程,f2说明OECNE能促进EDA释放;其吸收速率常数在胃部、十二指肠、空肠、回肠和结肠分别为EDA的2.32、2.74、3.36、4.13和2.74倍,有效渗透系数在4个肠段中分别为EDA的4.66、3.70、4.87和3.60倍,OECNE增加了在大鼠胃和不同肠段中药物的吸收。结论:OECNE改善了EDA的释放行为;OECNE提高了EDA的吸收。 Objective:To study its in vitro drug release of evodiamine nanocomplex oil-in-water nanoemulation(OECNE)and to inves- tigate its intestinal absorption. Methods:The dialysis was used to evaluate release profile, and the release behavior was studied by model and similarity factor f2. Single-pass intestinal perfusion was conducted to evaluate intestinal absorption. Results:The cumulative releases of OECNE were both about 3-fold that of EDA in 0.1 pH 1.2 hydrochloric acid solution and in pH 6.8 phosphate buffer solution, and OECNE was in accordance with Weibull model in two different solutions, and f2 also revealed OECNE have benefit in drug release. The intestinal absorption rate constant of OECNE was 2.32-fold, 2.74-fold, 3.36-fold,4.13-fold and 2.74-fold than that of free EDA in stomach,duodenum,jejunum, ileum and colon. The effective permeability of OECNE was 4.66-fold, 3.70-fold,4.87- fold and 3.60-fold than that of EDA. Conclusion : OECNE was successfully used to enhance the absorption of EDA.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2018年第1期135-138,共4页 Journal of Chongqing Medical University
基金 重庆市科委资助项目(编号:cstc2015jcyj BX0027)
关键词 吴茱萸碱 磷脂纳米复合物 纳米乳 体外释放 透析法 evodiamine drug-phospholipid nanocomplex nanoemulation drug release in vitro dialysis method
  • 相关文献

参考文献7

二级参考文献60

  • 1张海燕,平其能,郭健新,操锋.灯盏花素及其β-环糊精包合物在大鼠体内的药代动力学[J].药学学报,2005,40(6):563-567. 被引量:39
  • 2农克良,韦良兴,慕光杉,农容丰,石郦.姜黄色素的简易提取与柱色谱分离研究[J].化工技术与开发,2006,35(2):3-5. 被引量:6
  • 3齐莉莉,王进波.单体姜黄素稳定性的研究[J].食品工业科技,2007,28(1):181-182. 被引量:35
  • 4陈贤春,吴清,王玉蓉,李冀湘.关于溶出曲线比较和评价方法[J].中国医院药学杂志,2007,27(5):662-664. 被引量:66
  • 5刘建平,李高.生物药剂学与药物动力学[M].4版.北京:人民卫生出版社,2011:8-9.
  • 6Tan Q,Wu J,Li Y,Mei H, Zhao C, Zhang J. A su- permolecular curcumin for enhanced antiproliferative and proapoptotic activities: molecular characteristics, computer modeling and in vivo pharmacokinetics[J]. Nanotechnology, 2013,24 : 035102.
  • 7Maiti K, Mukherjee K, Gantait A, Saha B P, Mukherjee P K. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats [J]. Int J Pharm, 2007,330 : 155-163.
  • 8Yue G G,Cheng S W,Yu H,Xu Z S,Lee J K,Hon P M,et al. The role of turmerones on cureumin transpor- tation and P-glycoprotein activities in intestinal Caco-2 cells[J]. J Med Food, 2012,15 : 242-252.
  • 9Mazzolani F. Pilot study of oral administration of a cur- cumin-phospholipid formulation for treatment of central serous chorioretinopathy[J]. Clin Ophthalmol, 2012,6: 801-806.
  • 10汪海慧,成扬.姜黄素药理作用的研究进展[J].上海中医药大学学报,2007,21(6):73-76. 被引量:53

共引文献73

同被引文献61

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部